[HTML] sciencedirect.com

[HTML][HTML] Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing

F Yang, K Deng, H Zheng, Z Liu, Y Zheng - Annals of Hepatology, 2022 - Elsevier
Hepatocellular carcinoma (HCC), leading cancer worldwide, has a high degree of genetic
heterogeneity; next-generation sequencing (NGS) technology has contributed significantly …
被引用次数：7 相关文章

Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing.

F Yang, K Deng, H Zheng, Z Liu, Y Zheng - Annals of Hepatology, 2022 - europepmc.org
Hepatocellular carcinoma (HCC), leading cancer worldwide, has a high degree of genetic
heterogeneity; next-generation sequencing (NGS) technology has contributed significantly …

Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing

F Yang, K Deng, H Zheng, Z Liu… - Annals of …, 2022 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), leading cancer worldwide, has a high degree of genetic
heterogeneity; next-generation sequencing (NGS) technology has contributed significantly …

Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing.

F Yang, K Deng, H Zheng, Z Liu… - Annals of Hepatology …, 2022 - search.ebscohost.com
Hepatocellular carcinoma (HCC), leading cancer worldwide, has a high degree of genetic
heterogeneity; nextgeneration sequencing (NGS) technology has contributed significantly to …